To give you the best possible experience, this site uses cookies. Review our Privacy Policy and Terms of Service to learn more. Got it!

CMI Communications Podcasts

CMI Communications public [search 0]
Related Topics
Religion Fitness Medicine Infection Trial Salvation Army Infectious Diseases TSA Visual Communications David Q. Andrews Visual Communication Clinical Microbiology Escmid Antibiotic Stewardship
More
Download the App!
Get it on App Store Get it on Google Play
show episodes
 
Artwork

1
Communicable

CMI Communications

Unsubscribe
Unsubscribe
 Monthly+
 
Communicable takes on hot topics in infectious diseases and clinical microbiology. Hosted by the editors of CMI Communications, the open-access journal of ESCMID, the European Society of Clinical Microbiology & Infectious Diseases.
…   continue reading
 
Artwork

1
Rob Hayes

David Q. Andrews

Unsubscribe
Unsubscribe
 Monthly
 
Iv'e been producing and djing for a good few years now , my favourite styles of music are all things House, Garage and Drum and Bass. Over the years i've been lucky enough to get a few releases out there and had the chance to remix some really good tracks , feel free to check out my stuff , i'm frequently adding new tracks , and make tracks that I can available for download. I'm always interested in working on new tracks and if I like a track will often take it on to be remixed ... Best way ...
…   continue reading
 
Loading …
show series
 
Artwork

1
Communicable E7: Melioidosis goes global 52:08

Play Pause
52:08
Play Pause
  Play later
  Play later
  Lists
  Liked
52:08
 
Once considered endemic only to tropical and subtropical climates such as Southeast Asia and northern Australia, melioidosis is expanding to non-endemic areas such as the southern US. Climate change is impacting infectious diseases, melioidosis being no exception. Now is the time to inform and prepare: as this Communicable episode’s title indicates…
…   continue reading
 
Artwork

1
Communicable E6 – “Sneaky viruses”: an update on hepatitis B & C before World Hepatitis Day 54:06

Play Pause
54:06
Play Pause
  Play later
  Play later
  Lists
  Liked
54:06
 
Responsible for 1.3 million deaths and 2.2 million new infections per year, viral hepatitis is the second leading cause of morbidity and mortality amongst all infectious diseases, just behind tuberculosis. Hosts Angela Huttner and Oana Sandulescu welcome special guest and leading hepatitis expert, Professor Mojca Matičič, MD, PhD (Ljubljana, Sloven…
…   continue reading
 
Artwork

1
Communicable E5 - Beauty is in the 'I' of the beholder: EUCAST updates 38:31

Play Pause
38:31
Play Pause
  Play later
  Play later
  Lists
  Liked
38:31
 
The ‘I’ (intermediate susceptibility) in a EUCAST-guided antibiogram never meant impending resistance to your antibiotic. It was never meant to make you find the one ‘S’ (invariably a carbapenem) and use it instead—even if many clinicians did. In this episode of Communicable, hosts Marc Bonten and Angela Huttner welcome Profs. Christian Giske (outg…
…   continue reading
 
Artwork

1
Communicable E4 - The BLING-3 trial & continuous beta-lactam infusion: should these results change your practice? 44:52

Play Pause
44:52
Play Pause
  Play later
  Play later
  Lists
  Liked
44:52
 
Hosts Angela Huttner & Erin McCreary welcome Prof. David Paterson (Singapore) and Prof. Josh Davis (Newcastle, Australia) to discuss the design and results of the BLING-3 trial, which compared continuous infusion of beta-lactam antibiotics to standard intermittent dosing in 7000 critically ill patients across 104 intensive-care units. In unadjusted…
…   continue reading
 
Artwork

1
Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first? 42:58

Play Pause
42:58
Play Pause
  Play later
  Play later
  Lists
  Liked
42:58
 
What are WHO's most wanted bacterial pathogens in 2024? Hosts Angela Huttner & Oana Sandulescu welcome guests Dr. Hatim Sati of the World Health Organisation (WHO) and Dr. Erin Duffy (CARB-X) to discuss WHO’s new Priority Pathogens List. Developed by WHO and a panel of global experts, the List identifies the ‘top’ bacteria for which research & deve…
…   continue reading
 
Artwork

1
Communicable E2 - Phage therapy: does it work and will we have access? 54:00

Play Pause
54:00
Play Pause
  Play later
  Play later
  Lists
  Liked
54:00
 
In this episode, hosts Josh Davis (Newcastle, Australia) and Angela Huttner (Geneva, Switzerland) interview the phage ‘microbiologist-clinician duo’, Drs. Shawna McCallin and Lorenz Leitner (Balgrist Hospital, Zurich, Switzerland). They explore the history of phages, the process of bringing phage therapy to a patient, potential resistance to phages…
…   continue reading
 
Artwork

1
Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice? 58:02

Play Pause
58:02
Play Pause
  Play later
  Play later
  Lists
  Liked
58:02
 
CMI Communications editors Angela Huttner, Marc Bonten, and Erin McCreary discuss late-breaker clinical trials presented at ESCMID Global (ECCMID) in Barcelona, providing insights into the trials’ designs, results, and implications. The DOTS trial compared two doses of long-acting dalbavancin to standard of care in patients with complicated S. aure…
…   continue reading
 
Loading …

Quick Reference Guide

Top Podcasts
The Bill Simmons Podcast
PTI
First Take
Marketplace
Comedy of the Week
The Bugle
How Did This Get Made?
Doug Loves Movies
Planet Money
TED Talks Daily
NBC Nightly News with Lester Holt
The World This Hour
Daily Boost Motivation and Coaching
Radiolab
Science Friday
This American Life
Criminal
Sword and Scale
In The Dark
Player FM logo
Help/FAQ | Upgrade | Advertise
Arts|Business|Comedy|Economics|Entertainment|News|Politics|Religion
Science|Soccer|Sports|Storytelling|Technology|True Crime
Copyright 2024 | Sitemap | Privacy Policy | Terms of Service | | Copyright
Episode being played series thumbnail
icon icon
Speed
Series settings
1x
1x
Volume
100%
icon
icon icon
/

View Player FM in...
Player FM
Browser
Chrome
Safari
Firefox